Release Date: 07/03/23 13:06 Summary: Dispatch of Bidder's Statement Price Sensitive: Yes Download Document 1.13MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%